05.02.2013 Views

Role of Intestinal Microbiota in Ulcerative Colitis

Role of Intestinal Microbiota in Ulcerative Colitis

Role of Intestinal Microbiota in Ulcerative Colitis

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

1042 J. Holck et al. / Process Biochemistry 46 (2011) 1039–1049<br />

Table 2<br />

16S rRNA primers for real time PCR.<br />

Target gene Forward primer (5 ′ –3 ′ ) Reverse primer (5 ′ –3 ′ ) Product<br />

size (bp)<br />

Correlation<br />

coefficient (R 2 )<br />

Efficiency (%) Reference<br />

Firmicutes phylum gga gya tgt ggt tta att cga agc a agc tga cga caa cca tgc ac 126 0.999 101 [51]<br />

Bacteroidetes phylum gga rca tgt ggt tta att cga tga t agc tga cga caa cca tgc ag 126 0.999 99 [51]<br />

Total bacteria a cgg caa cga gcg caa ccc cca ttg tag cac gtg tgt agc c 130 0.999 99 [52]<br />

a PCR for the total bacteria primer set was run <strong>in</strong> parallel for each set <strong>of</strong> primers for all samples.<br />

from 80 to 550 mM ammonium formate for 20.25 CV. Collection <strong>of</strong> peaks <strong>of</strong> <strong>in</strong>terest<br />

was performed us<strong>in</strong>g a level fractionation parameter. To obta<strong>in</strong> the oligomers <strong>in</strong> the<br />

RGI permeate, a sample was <strong>in</strong>jected on the column and eluted us<strong>in</strong>g a l<strong>in</strong>ear gradient<br />

from 20 to 400 mM ammonium formate for 30 CV. Fractionation was performed<br />

us<strong>in</strong>g an elution volume as the fractionation parameter. The collected fractions for<br />

both types <strong>of</strong> oligomers were lyophilized to remove water and ammonium formate<br />

[33,34] and analyzed by MALDI-MS and MS/MS.<br />

2.11. MALDI-MS<br />

All mass-spectrometric analysis <strong>of</strong> the oligosaccharides was performed on a<br />

4800 Plus MALDI TOF/TOF TM (AB SCIEX) mass spectrometer. 0.5 �l <strong>of</strong> the sample<br />

was applied to a sta<strong>in</strong>less steel MALDI target and mixed with 0.5 �l <strong>of</strong> the<br />

matrix, �-cyano-4-hydroxy-c<strong>in</strong>namic acid dissolved at a concentration <strong>of</strong> 10 mg/mL<br />

<strong>in</strong> 70%ACN/0.1% TFA/water. The <strong>in</strong>strument was operated <strong>in</strong> negative ion reflector<br />

mode and the m/z range from 100 to 3500 was monitored. A total <strong>of</strong> around 1000<br />

laser shots were applied to each sample <strong>in</strong> MS mode. In MS/MS mode around 2000<br />

shots were obta<strong>in</strong>ed. The laser <strong>in</strong>tensity was manually varied <strong>in</strong> order to obta<strong>in</strong> the<br />

best possible spectra (MS: from 4500 to 4800. MS/MS: from 4800 to 5100). MALDI-<br />

TOF-MS and MS/MS data were exported as text files us<strong>in</strong>g DataExplorer (version 4.0)<br />

and each spectrum were smoothed, labeled and analyzed manually <strong>in</strong> m/z (Genomic<br />

Solutions ® ). For annotation <strong>of</strong> MS/MS spectra, the nomenclature suggested <strong>in</strong> [35]<br />

was applied.<br />

2.12. Comb<strong>in</strong>ed acid and enzymatic hydrolysis<br />

The monosaccharide composition <strong>of</strong> all fractions were determ<strong>in</strong>ed by a comb<strong>in</strong>ed<br />

acid and enzymatic hydrolysis modified from Garna et al. [36]. Each substrate<br />

was treated <strong>in</strong> 4 mL f<strong>in</strong>al volume <strong>of</strong> 0.2 M trifluoroacetic acid hav<strong>in</strong>g a substrate<br />

concentration <strong>of</strong> 2.5 g/L for 72 h at 80 ◦ C. After acid hydrolysis, pH was adjusted to 5<br />

us<strong>in</strong>g 500 mM acetate buffer pH 5, followed by 5 M NaOH. The acid hydrolysate was<br />

treated with Viscozyme (Novozymes A/S, Bagsvaerd, Denmark) for 24 h at 50 ◦ Cas<br />

described <strong>in</strong> [36]. Samples were filtered through a 0.2 �m filter prior to HPAEC-PAD<br />

analysis. The recovery <strong>of</strong> monosaccharides was determ<strong>in</strong>ed by perform<strong>in</strong>g the same<br />

hydrolysis on d-fucose, l-rhamnose, d-arab<strong>in</strong>ose, d-galactose, d-glucose, d-xylose,<br />

d-galacturonic acid and d-glucuronic acid. The recovery factors were used to quantify<br />

the monosaccharides. Relative standard deviation values were determ<strong>in</strong>ed for<br />

at least 3 measurements and ranged from 2 to 14%. The amount <strong>of</strong> fucose was below<br />

the quantification limit <strong>in</strong> all fractions.<br />

2.13. HPAEC analysis<br />

Quantification <strong>of</strong> the monosaccharides was performed by HPAEC-PAD us<strong>in</strong>g<br />

an ICS-3000 system consist<strong>in</strong>g <strong>of</strong> a gradient pump (model DP-1), an electrochemical<br />

detector/chromatography module (model DC-1) coupled to an autosampler<br />

(Dionex Corp., Sunnyvale, CA). The separation was made us<strong>in</strong>g a CarboPac TM PA20<br />

(3 mm × 150 mm) analytical column based on a method <strong>of</strong> [37] with the follow<strong>in</strong>g<br />

modifications: a two-eluent system compris<strong>in</strong>g deionized water and a 0.5 M NaOH<br />

aqueous solution was used. Before <strong>in</strong>jection <strong>of</strong> each sample (10 �l) the column was<br />

reequilibrated with 15 mM NaOH for 10 m<strong>in</strong>. After <strong>in</strong>jection <strong>of</strong> the sample a l<strong>in</strong>ear<br />

gradient from 15 mM NaOH to 5 mM NaOH from 0 to 1.5 m<strong>in</strong> was applied, followed<br />

by isocratic elution with 5 mM NaOH from 1.5 to 3 m<strong>in</strong>, another l<strong>in</strong>ear gradient from<br />

5 mM NaOH to 2.5 mM NaOH from 3 to 7 m<strong>in</strong>, another isocratic elution with 2.5 mM<br />

NaOH from 7 to 12 m<strong>in</strong>, and a f<strong>in</strong>al isocratic elution with 500 mM NaOH from 12 to<br />

25 m<strong>in</strong>. The eluent flow rate was always kept at 0.5 mL/m<strong>in</strong>. The quantification was<br />

carried out us<strong>in</strong>g the external monosaccharide standards: d-fucose, l-rhamnose,<br />

d-arab<strong>in</strong>ose, d-galactose, d-glucose, d-xylose and d-galacturonic acid. The follow<strong>in</strong>g<br />

pulse potentials and durations were used for detection: E1 = 0.1 V, t1 = 400 ms;<br />

E2=− 2V, t2=20ms; E3 = 0.6 V, m3=10ms; E4=− 0.1 V, t4 = 70 ms. Data were collected<br />

and analyzed with the program Chromeleon 6.80 SP4 Build 2361 s<strong>of</strong>tware<br />

(Dionex Corp., Sunnyvale, CA).<br />

2.14. Subjects and faecal samples<br />

Faecal samples were obta<strong>in</strong>ed from 6 patients with ulcerative colitis (UC) and 3<br />

healthy volunteers. With<strong>in</strong> the UC group, 3 patients were <strong>in</strong> remission and 3 patients<br />

were <strong>in</strong> relapse at the time <strong>of</strong> sampl<strong>in</strong>g. None <strong>of</strong> the participants had been treated<br />

with antibiotics for at least 2 months before enrolment, and the 3 healthy volunteers<br />

had no history <strong>of</strong> gastro<strong>in</strong>test<strong>in</strong>al disorder. There was no significant difference <strong>in</strong> the<br />

mean age <strong>of</strong> the participants compar<strong>in</strong>g the 3 groups (healthy control: 42.7 ± 10.0<br />

years, UC patients <strong>in</strong> remission: 36.0 ± 5.0 years and UC patients <strong>in</strong> relapse: 44.3 ± 5.5<br />

years). Whole stools were collected <strong>in</strong> airtight conta<strong>in</strong>ers, immediately stored at<br />

4 ◦ C and processed with<strong>in</strong> 12 h. 200 mg wet weight faeces were collected for DNA<br />

extraction, and at the same time, faeces were prepared for <strong>in</strong> vitro fermentation.<br />

The faecal samples for <strong>in</strong> vitro fermentation were homogenised <strong>in</strong> 50% glycerol (1:1<br />

dilution) <strong>in</strong> an anaerobic cab<strong>in</strong>et (conta<strong>in</strong><strong>in</strong>g 10% H2, 10% CO2, and 80% N2) and<br />

stored at −80 ◦ C until further analysis.<br />

2.15. In vitro fermentation<br />

A small scale <strong>in</strong> vitro fermentation method was developed to assess the fermentability<br />

<strong>of</strong> selected oligosaccharides on human faecal samples. Sterile filtered<br />

homogalacturonan oligosaccharides DP4 and DP5 were added to autoclaved m<strong>in</strong>imal<br />

basal medium to give a f<strong>in</strong>al concentration <strong>of</strong> 5 g/L <strong>in</strong> a total reaction volume <strong>of</strong><br />

2 mL. The solutions were reduced <strong>in</strong> an anaerobic cab<strong>in</strong>et over night. The m<strong>in</strong>imal<br />

basal medium conta<strong>in</strong>ed, per liter, 2 g <strong>of</strong> peptone water, 1 g <strong>of</strong> yeast extract, 0.1 g <strong>of</strong><br />

NaCl, 0.04 g <strong>of</strong> K2HPO4, 0.04 g <strong>of</strong> KH2PO4, 0.01 g <strong>of</strong> MgSO4·7H2O, 0.01 g <strong>of</strong> CaCl2·2H2O,<br />

2 g <strong>of</strong> NaHCO3, 0.5 g <strong>of</strong> bile salts, 0.5 g <strong>of</strong> l-cyste<strong>in</strong>e hydrochloride, 0.005 g <strong>of</strong> hem<strong>in</strong>,<br />

10 �l <strong>of</strong> vitam<strong>in</strong> K1(0.02 mM), 2 ml <strong>of</strong> Tween 80, and 1 mL <strong>of</strong> 0.05% (w/v) resazur<strong>in</strong><br />

solution. A 10% (w/v) faecal slurry was prepared by mix<strong>in</strong>g the faeces diluted <strong>in</strong> 50%<br />

glycerol with anoxic PBS (Oxoid, Greve, Denmark). The reduced m<strong>in</strong>imal medium<br />

with added oligosaccharide was <strong>in</strong>oculated with the faecal slurry to a f<strong>in</strong>al concentration<br />

<strong>of</strong> 1% (w/v) faeces. The fermentations were performed at 37 ◦ C for 24 h <strong>in</strong> an<br />

anaerobic cab<strong>in</strong>et.<br />

2.16. Extraction <strong>of</strong> bacterial DNA<br />

DNA was extracted from faecal and fermentation samples us<strong>in</strong>g the QIAamp<br />

DNA Stool M<strong>in</strong>i Kit (Qiagen, Hilden, Germany) with a bead-beater step <strong>in</strong> advance,<br />

as described by Leser et al. [38]. The purified DNA was stored at −20 ◦ C until use.<br />

2.17. Real-time PCR assay conditions<br />

Amplification and detection <strong>of</strong> purified bacterial DNA by real-time PCR were performed<br />

with the ABI-Prism 7900 HT from Applied Biosystems us<strong>in</strong>g optical grade<br />

384-well plates. Primers specifically target<strong>in</strong>g 16S rRNA gene sequences <strong>of</strong> the Bacteroidetes<br />

and Firmicutes phyla, respectively, were <strong>in</strong>cluded <strong>in</strong> the qPCR analysis<br />

(Table 2). The amplification reactions were carried out <strong>in</strong> a total volume <strong>of</strong> 10 �l<br />

conta<strong>in</strong><strong>in</strong>g; 5 �l EXPRESS SYBR ® GreenER TM qPCR SuperMix (Invitrogen A/S, Taastrup,<br />

Denmark), 10 pmol <strong>of</strong> each <strong>of</strong> the primers (Eur<strong>of</strong><strong>in</strong>s MWG Synthesis GmbH,<br />

Ebersberg, Germany), 2 �l template DNA, and Nuclease-free water (Qiagen) purified<br />

for PCR. The amplification program consisted <strong>of</strong> one cycle at 50 ◦ C for 2 m<strong>in</strong>;<br />

one cycle at 95 ◦ C for 10 m<strong>in</strong>; 40 cycles at 95 ◦ C for 15 sec and 60 ◦ C for 1 m<strong>in</strong>; and<br />

f<strong>in</strong>ally one cycle <strong>of</strong> melt<strong>in</strong>g curve analysis for amplicon specificity at 95 ◦ C for 15 s,<br />

60 ◦ C for 20 s and <strong>in</strong>creas<strong>in</strong>g ramp rate by 2% until 95 ◦ for 15 s.<br />

2.18. Realtime PCR data handl<strong>in</strong>g<br />

The threshold cycle (Ct) values and basel<strong>in</strong>e sett<strong>in</strong>gs were determ<strong>in</strong>ed by<br />

automatic analysis sett<strong>in</strong>gs set by the ABI s<strong>of</strong>tware. The relative changes <strong>in</strong> the<br />

abundancy <strong>of</strong> gene targets encod<strong>in</strong>g 16S rRNA <strong>of</strong> Bacteroidetes and Firmicutes were<br />

calculated us<strong>in</strong>g the approximation 2 −Ct . Ct is the threshold cycle calculated by the<br />

ABI s<strong>of</strong>tware as the PCR cycle, where amplifications signal exceeds the selected<br />

threshold value, also set by the s<strong>of</strong>tware. The amounts <strong>of</strong> phylum specific DNA targets<br />

were normalized to total bacteria DNA targets <strong>in</strong> order to correct for differences<br />

<strong>in</strong> total DNA concentration between <strong>in</strong>dividual samples [39]. Standard curves were<br />

created us<strong>in</strong>g serial 10-fold dilutions <strong>of</strong> bacterial DNA extracted from one <strong>of</strong> the<br />

fermentation samples for all primer sets. Analysis <strong>of</strong> the standard curves allowed<br />

verification <strong>of</strong> PCR efficiency for the chosen PCR conditions (Table 2). All results were<br />

calculated as means <strong>of</strong> duplicate determ<strong>in</strong>ations.<br />

2.19. Statistical analysis<br />

Statistical analysis <strong>of</strong> quantitative PCR data was done us<strong>in</strong>g the GraphPad Prism<br />

(version 5.03). Data was analyzed by one-way ANOVA followed by a pair-wise multiple<br />

comparison <strong>of</strong> means (Student’s t). Tests were considered statistically significant<br />

if P values

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!